0001236031-14-000007.txt : 20140304
0001236031-14-000007.hdr.sgml : 20140304
20140304100358
ACCESSION NUMBER: 0001236031-14-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140226
FILED AS OF DATE: 20140304
DATE AS OF CHANGE: 20140304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE CLARA MAXIMILIAN
CENTRAL INDEX KEY: 0001236031
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 14662914
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-02-26
0
0000725363
CEL SCI CORP
cvm
0001236031
DE CLARA MAXIMILIAN
1
1
0
0
President
Options
1.09
2014-02-26
4
A
0
75000
0
A
2024-02-25
Common Stock
75000
620825
D
The stock options vest in three (3) equal annual installments commencing one year after the grant date.
Maxamilian de Clara
2014-03-04